Skip to main content
Atrás
Watch Compare

Bio Essence Corp

Calidad de datos: 100%
BIOE
OTC Manufacturing Chemicals
$0.25
$0.00 (0.00%)
Cap. Mercado: 9.50 M
Precio
$0.25
Cap. Mercado
9.50 M
Rango del Día
$0.20 — $0.30
Rango de 52 Semanas
$0.05 — $0.30
Volumen
25,317
Apertura $0.20
Promedio 50D / 200D
$0.08
201.93% above
Promedio 50D / 200D
$0.08
206.00% above

Quick Summary

Puntos Clave

Revenue grew 20.91% annually over 5 years — strong growth
Net margin of 47.23% shows strong profitability
Generating 1.57 M in free cash flow
P/E of 10.60 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 464.87%
Cash machine — converts 175.16% of earnings into free cash flow

Crecimiento

Revenue Growth (5Y)
20.91%
Above sector avg (1.82%)
Revenue (1Y)485.78%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net Margin47.23%
Op. Margin47.43%

Seguridad

Debt / Equity
N/A
Current Ratio0.06
Interest Coverage411.72

Valoración

PE (TTM)
10.60
Above sector avg (-1.47)
P/B RatioN/A
EV/EBITDA10.59
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E 10.6 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % 47.2 -41.5
Rev Growth 5Y % 20.9 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 485.78% Revenue Growth (3Y) 85.49%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 20.91% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.90 M Net Income (TTM) 896,197.0
ROE N/A ROA 603.04%
Gross Margin 75.28% Operating Margin 47.43%
Net Margin 47.23% Free Cash Flow (TTM) 1.57 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.06
Interest Coverage 411.72 Asset Turnover 12.77
Working Capital -3.05 M Tangible Book Value -3.10 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 10.60 Forward P/E N/A
P/B Ratio N/A P/S Ratio 5.01
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 10.59 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 16.52%
Market Cap 9.50 M Enterprise Value 9.53 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.05
FCF / Share 0.04 OCF / Share 0.04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 175.16%
SBC-Adj. FCF N/A Growth Momentum 464.87

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.90 M 323,940.0 551,506.0 985,757.0 887,984.0
Net Income 896,197.0 -1.31 M -971,879.0 -809,679.0 -647,564.0
EPS (Diluted) — -0.03 -0.02 -0.02 —
Gross Profit 1.43 M 217,077.0 277,446.0 384,949.0 298,324.0
Operating Income 900,011.0 -459,438.0 -789,050.0 -782,804.0 -857,527.0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 235.0 911.0 17,418.0 53,977.0 35,802.0
Interest Expense 2,186.0 2,153.0 17,344.0 — 38,558.0
Income Tax 800.0 800.0 2,400.0 3,300.0 3,300.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 422,474.0 281,024.0 2.66 M 1.55 M 1.70 M
Total Liabilities 2.50 M 3.25 M 4.32 M 4.79 M 4.13 M
Shareholders' Equity -2.07 M -2.97 M -1.66 M -3.24 M -2.43 M
Total Debt 57,482.0 56,481.0 — — —
Cash & Equivalents — 1,371.0 114.0 6,262.0 303.0
Current Assets 422,377.0 280,692.0 1.10 M 203,831.0 261,962.0
Current Liabilities 2.44 M 2.80 M 3.18 M 3.56 M 2.76 M